Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions
HIVPremature Aging
Interventions
DIETARY_SUPPLEMENT

Probiotic

"The probiotic i3.1 is a commercialized product. It will be supplied by the promoter and manufactured in ALIFARM S.A.~It contains:~* Lactobacillus plantarum CECT7484~* Lactobacillus plantarum CECT7485~* Pediococcus acidilactici CECT7483"

DIETARY_SUPPLEMENT

Prebiotic

"ProSeed prebiotic is a non-commercialized product. It will be supplied by the promoter and manufactured in ALIFARM S.A.~It contains:~* Partially Hydrolyzed Guar Gum (PHGG)~* Inulin HPD~* Oat Beta-Glucans~* Pectin~* Inulin Low Protein Diet (LPD)~* Polydextrose~* Maltrodextrins"

DIETARY_SUPPLEMENT

Placebo

It is a non-commercialized product. It is composed of the same excipients as the probiotic and the prebiotic. It will be supplied by the promoter and manufactured in ALIFARM S.A.

Trial Locations (1)

08916

Hospital Germans Trias i Pujol, Badalona

All Listed Sponsors
collaborator

Germans Trias i Pujol Hospital

OTHER

lead

AB Biotics, SA

INDUSTRY

NCT03542786 - Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic | Biotech Hunter | Biotech Hunter